NM_014363.6(SACS):c.8873A>G (p.Lys2958Arg) AND Charlevoix-Saguenay spastic ataxia

Germline classification:: Benign (1 submission)
Last evaluated:: Sep 16, 2020
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001274927.1

Allele description [Variation Report for NM_014363.6(SACS):c.8873A>G (p.Lys2958Arg)]

NM_014363.6(SACS):c.8873A>G (p.Lys2958Arg)

Gene:

SACS:sacsin molecular chaperone [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

13q12.12

Genomic location:

Preferred name:

NM_014363.6(SACS):c.8873A>G (p.Lys2958Arg)

HGVS:

NC_000013.11:g.23335003T>C
NG_012342.1:g.103700A>G
NM_001278055.2:c.8432A>G
NM_014363.6:c.8873A>GMANE SELECT
NP_001264984.1:p.Lys2811Arg
NP_055178.3:p.Lys2958Arg
NC_000013.10:g.23909142T>C
NM_014363.4:c.8873A>G
NM_014363.5:c.8873A>G
Q9NZJ4:p.Lys2958Arg

Protein change:

K2811R

Links:

UniProtKB: Q9NZJ4#VAR_059719; dbSNP: rs11839380

NCBI 1000 Genomes Browser:

rs11839380

Molecular consequence:

NM_001278055.2:c.8432A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_014363.6:c.8873A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Charlevoix-Saguenay spastic ataxia (SACS)
Synonyms:: Autosomal recessive spastic ataxia of Charlevoix-Saguenay; Spastic ataxia of Charlevoix-Saguenay; SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE
Identifiers:: MONDO: MONDO:0010041; MedGen: C1849140; Orphanet: 98; OMIM: 270550

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001459487	Natera, Inc.	no assertion criteria provided	Benign (Sep 16, 2020)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001459487

Natera, Inc.

no assertion criteria provided

Benign
(Sep 16, 2020)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Natera, Inc., SCV001459487.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 16, 2024

ClinVar

Relating variation to medicine